{"id":"https://openalex.org/W16747851","doi":null,"title":"[The results of longitudinal use of copaxone and betaferon in Moscow Multiple Sclerosis Center: issues of efficacy and adherence to therapy].","display_name":"[The results of longitudinal use of copaxone and betaferon in Moscow Multiple Sclerosis Center: issues of efficacy and adherence to therapy].","publication_year":2006,"publication_date":"2006-01-01","ids":{"openalex":"https://openalex.org/W16747851","mag":"16747851","pmid":"https://pubmed.ncbi.nlm.nih.gov/17172244"},"language":"ru","primary_location":{"id":"pmid:17172244","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17172244","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112212335","display_name":"\u0410. \u041d. \u0411\u043e\u0439\u043a\u043e","orcid":"https://orcid.org/0000-0003-2697-7605","observed_orcids":["https://orcid.org/0000-0003-2697-7605","https://orcid.org/0000-0003-3306-9541"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A N Bo\u012dko","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008228556","display_name":"Davydovskaia Mf","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M F Davydovskaia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038070142","display_name":"Demina Tl","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T L Demina","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014469457","display_name":"N. Yu. Lashch","orcid":"https://orcid.org/0000-0003-2826-0560","observed_orcids":["https://orcid.org/0000-0003-2826-0560"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N Iu Lashch","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044667682","display_name":"Ovcharov Vv","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V V Ovcharov","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009025695","display_name":"\u041d \u0424 \u041f\u043e\u043f\u043e\u0432\u0430","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N F Popova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008141936","display_name":"N I Sinbukhova","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N I Sinbukhova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041117729","display_name":"\u041d. \u0412. \u0425\u0430\u0447\u0430\u043d\u043e\u0432\u0430","orcid":"https://orcid.org/0000-0002-4943-4630","observed_orcids":["https://orcid.org/0000-0002-4943-4630"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N V Khachanova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041074430","display_name":"Sergey G Shchur","orcid":"https://orcid.org/0000-0002-1715-0465","observed_orcids":["https://orcid.org/0000-0002-1715-0465"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S G Shchur","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5036549747","display_name":"Evgeny I. Gusev","orcid":"https://orcid.org/0000-0003-0742-6875","observed_orcids":["https://orcid.org/0000-0003-0742-6875"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E I Gusev","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.00182548,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"Spec No 3","issue":null,"first_page":"101","last_page":"10"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11827","display_name":"Polyomavirus and related diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.996999979019165},{"id":"https://openalex.org/keywords/glatiramer-acetate","display_name":"glatiramer acetate","score":0.8939999938011169},{"id":"https://openalex.org/keywords/interferon-beta-1b","display_name":"interferon beta-1b","score":0.9359999895095825},{"id":"https://openalex.org/keywords/interferon-beta","display_name":"interferon-beta","score":0.6600000262260437},{"id":"https://openalex.org/keywords/disease-modifying-therapy","display_name":"disease-modifying therapy","score":0.9620000123977661},{"id":"https://openalex.org/keywords/relapse-rate","display_name":"relapse rate","score":0.953000009059906},{"id":"https://openalex.org/keywords/secondary-progressive-multiple-sclerosis","display_name":"secondary progressive multiple sclerosis","score":0.8669999837875366},{"id":"https://openalex.org/keywords/relapsing-remitting-multiple-sclerosis","display_name":"relapsing-remitting multiple sclerosis","score":0.8939999938011169},{"id":"https://openalex.org/keywords/treatment-withdrawal","display_name":"treatment withdrawal","score":0.6809999942779541},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.828000009059906},{"id":"https://openalex.org/keywords/edss-progression","display_name":"EDSS progression","score":0.8809999823570251},{"id":"https://openalex.org/keywords/long-term-treatment-outcomes","display_name":"long-term treatment outcomes","score":0.5680000185966492}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.938854455947876},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.7639043927192688},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46923500299453735},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3413935899734497},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.10700759291648865}],"mesh":[{"descriptor_ui":"D000068576","descriptor_name":"Interferon beta-1b","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000068717","descriptor_name":"Glatiramer Acetate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000276","descriptor_name":"Adjuvants, Immunologic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016899","descriptor_name":"Interferon-beta","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":1,"locations":[{"id":"pmid:17172244","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17172244","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2170874754","https://openalex.org/W2409576360","https://openalex.org/W2470980608","https://openalex.org/W2005506388","https://openalex.org/W2581522745","https://openalex.org/W2080543874","https://openalex.org/W1529192025","https://openalex.org/W45124210","https://openalex.org/W2151185538","https://openalex.org/W2019383113"],"abstract_inverted_index":{"In":[0,202],"last":[1],"decades,":[2],"practical":[3],"neurologists":[4],"are":[5,75],"able":[6],"to":[7,127,184,217,276,282,311],"use":[8],"DMT":[9,26,45,126,312],"in":[10,14,168,313],"multiple":[11,38],"sclerosis":[12,39],"(MS)":[13],"every":[15],"day":[16],"practice.":[17,316],"This":[18,101],"paper":[19],"presents":[20],"data":[21,109],"of":[22,25,31,37,56,60,69,91,107,110,145,151,170,179,209,243,255,273,278,292,298,305],"3-year":[23],"study":[24],"(copaxone":[27],"and":[28,47,64,66,136,249,286,295,309],"betaferon)":[29],"treatment":[30,61,112,257],"280":[32],"patients":[33,42,146,191,204,225],"with":[34,87,99,115,174,193,205,227],"definite":[35],"diagnosis":[36],"(MS),":[40],"166":[41],"regularly":[43],"receiving":[44],"(104--copaxone":[46],"62--betaferon)":[48],"for,":[49],"at":[50,154],"least,":[51,155],"3":[52,131],"years.":[53],"Clinical":[54],"symptoms":[55],"the":[57,67,73,108,161,177,207,240,244,252,256,271,279,290,293,296,303],"patients,":[58],"reasons":[59],"withdrawal":[62,74],"(48--copaxone":[63],"31--betaferon)":[65],"features":[68],"MS":[70,85,96,280],"course":[71,86,97,281],"after":[72],"analyzed.":[76],"Patients":[77],"who":[78],"received":[79],"betaferon":[80,175],"previously":[81,194],"had":[82,93],"more":[83],"severe":[84],"frequent":[88],"relapses,":[89],"half":[90],"them":[92,152],"secondary":[94],"progressive":[95],"(SPMS)":[98],"relapses.":[100],"made":[102],"impossible":[103],"a":[104],"direct":[105],"comparison":[106],"two":[111],"groups.":[113],"Treatment":[114,173],"copaxone":[116],"reduced":[117],"5":[118],"times":[119],"annual":[120],"relapse":[121,157,180,210],"rate,":[122],"from":[123,182,215],"1.45":[124],"before":[125,160],"0.27":[128],"during":[129],"these":[130,171],"years":[132],"(p":[133],"<":[134,222],"0.001),":[135],"this":[137],"reduction":[138,178,208],"remained":[139],"stable.":[140],"For":[141],"36":[142,200,236],"months,":[143],"40.4%":[144],"were":[147,247,250],"relapse-free":[148,198],"though":[149],"all":[150],"had,":[153],"one":[156],"per":[158,186],"year":[159,187],"treatment.":[162],"No":[163],"EDSS":[164,233,274],"progression":[165,234],"was":[166,212,261],"observed":[167],"80%":[169],"patients.":[172],"caused":[176,262],"rate":[181,211],"1,84":[183],"0,69":[185],"(2.7":[188],"times),":[189],"8":[190],"(26%)":[192],"active":[195],"RMS":[196],"being":[197],"for":[199,235],"months.":[201],"31":[203],"SPMS,":[206],"also":[213],"significant,":[214],"1.89":[216],"0.49":[218],"(3.8":[219],"times,":[220],"p":[221],"0.001).":[223],"Twenty-two":[224],"(71%)":[226],"previous":[228],"SPMS":[229,283],"did":[230],"not":[231,251],"have":[232],"months":[237],"that":[238],"indicate":[239],"positive":[241],"effect":[242],"therapy.":[245],"Side-effects":[246],"moderate":[248],"main":[253],"cause":[254],"withdrawal.":[258],"The":[259],"latter":[260],"mainly":[263],"by":[264,270,289],"clinical":[265],"un":[266],"efficacy,":[267],"most":[268],"frequently":[269],"increase":[272],"due":[275],"transformation":[277],"without":[284],"relapses":[285],"poor":[287],"understanding":[288],"patient":[291],"goals":[294],"possibilities":[297],"DMT.":[299],"These":[300],"facts":[301],"stress":[302],"significance":[304],"improving":[306],"compliance,":[307],"motivation":[308],"adherence":[310],"everyday":[314],"neurological":[315]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-06-24T00:00:00"}